Platinum nanoparticles for selective treatment of liver cancer cells

In recent years, the number of targeted cancer drugs has continued to rise. However, conventional chemotherapeutic agents still play an important role in cancer treatment. These include platinum-based cytotoxic agents that attack and kill cancer cells. But these agents also damage healthy tissue and cause severe side effects. Researchers at ETH Zurich have now identified an approach that allows for a more selective cancer treatment with drugs of this kind. Continue reading “Platinum nanoparticles for selective treatment of liver cancer cells”

Blog at WordPress.com.

Up ↑